Effects of flecainide on left ventricular pressure gradient and symptoms in obstructive hypertrophic cardiomyopathy: a comparison of flecainide and disopyramide-Reference-Cited by-同舟云学术

Effects of flecainide on left ventricular pressure gradient and symptoms in obstructive hypertrophic cardiomyopathy: a comparison of flecainide and disopyramide

Published:2014-06-12 Issue:5 Volume:30 Page:604-610
ISSN:0910-8327
Container-title:Heart and Vessels
language:en
Short-container-title:Heart Vessels

Author:

Haruki Shintaro,Minami Yuichiro,Suzuki Atsushi,Hagiwara Nobuhisa

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00380-014-0534-3.pdf

Reference30 articles.

1. Maron BJ (2002) Hypertrophic cardiomyopathy: a systematic review. J Am Med Assoc 287:1308–1320

2. Spirito P, Seidman CE, McKenna WJ, Maron BJ (1997) The management of hypertrophic cardiomyopathy. N Engl J Med 336:775–785

3. McKenna WJ, Behr ER (2002) Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death. Heart 87:169–176

4. Kawarai H, Kajimoto K, Minami Y, Hagiwara N, Kasanuki H (2011) Risk of sudden death in end-stage hypertrophic cardiomyopathy. J Card Fail 17:459–464

5. Fujita E, Nakanishi T, Nishizawa T, Hagiwara N, Matsuoka R (2013) Mutations in the cardiac troponin T gene show various prognoses in Japanese patients with hypertrophic cardiomyopathy. Heart Vessel 28:785–794

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spezielle medikamentöse und interventionelle Therapieverfahren der hypertrophen Kardiomyopathie;Aktuelle Kardiologie;2024-05-29

2. From Atrial Fibrillation Management to Atrial Myopathy Assessment: The Evolving Concept of Left Atrium Disease in Hypertrophic Cardiomyopathy;Canadian Journal of Cardiology;2024-05

3. Hypertrophic Cardiomyopathy: Current Treatment and Future Options;Current Problems in Cardiology;2023-04

4. Stellate ganglia stimulation counteracts vagal stimulation by significantly increasing heart rate and blood pressure;Journal of Interventional Cardiac Electrophysiology;2023-03-09

5. The many NOs to the use of Class IC antiarrhythmics: weren’t the guidelines too strict?;European Heart Journal Supplements;2022-11-12